Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.

Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.

Item
http://www.wikidata.org/entity/Q36236568
MEK5/ERK5 pathway: the first fifteen yearsEnhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancerUse of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyCross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerAccelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.The recurrence frequency of breast cancer and its prognostic factors in Iranian patients.The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases.Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies.MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: a phase II study.Cancer endocrinology through own experience: areas for further thought and development. Interview by Natasha Galukande.
P2860

Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.

Item
http://www.wikidata.org/entity/Q36236568
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Consensus statement. Workshop ...... ications for future treatment.
@ast
Consensus statement. Workshop ...... ications for future treatment.
@en
type
label
Consensus statement. Workshop ...... ications for future treatment.
@ast
Consensus statement. Workshop ...... ications for future treatment.
@en
prefLabel
Consensus statement. Workshop ...... ications for future treatment.
@ast
Consensus statement. Workshop ...... ications for future treatment.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P698
P921
P356
P1433
P1476
Consensus statement. Workshop ...... lications for future treatment
@en
P2093
P304
P31
P356
P478
P50
P577
P698
P921